NCT00723242View on ClinicalTrials.gov

The Role of Dendritic Cells in Hepatitis C Infection

NACompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

Viraferon-peg and Rebetol

Trial Locations (1)

NW1 2BU

University College Hospital, London

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

University College, London

OTHER

NCT00723242 - The Role of Dendritic Cells in Hepatitis C Infection | Biotech Hunter | Biotech Hunter